Abstract:Bioactive phospholipids (PL) from different origins varied greatly in the chemical constitutions, especially the fatty acid compositions, which might influence its physiological activities in turn. In the study, egg yolk phospholipids (EGG‐PL), soybean phospholipids (SOY‐PL), and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) were administered to high fat (HF) diet‐induced obese C57BL/6J mice for 7 weeks to compare their effects on obesity‐related metabolic disorders. EGG‐PL, SOY‐PL, and DHA‐PL significantly decreased epididymal adipose tissue weights, reduced blood pressures and lowered hepatic TG levels. Only DHA‐PL efficiently decreased perirenal adipose tissue weights, and reduced serum glucose, insulin, IL‐6 and TG levels. These three phospholipids significantly decreased delta‐9 desaturation indices, the ratio of oleic acid versus stearic acid, and reduced the enzyme activities and gene expressions of FAS in the liver, while DHA‐PL also markedly reduced mRNA levels of SREBP‐1c and SCD‐1. Hepatic total catalase and peroxisomal β‐oxidation activities were significantly increased after DHA‐PL supplementation. These data indicated that the biological effects of PL with different fatty acid compositions were not completely equivalent and DHA‐PL, rich in n‐3 PUFA, was more efficient in ameliorating obesity‐related metabolic disorders, especially the lipid metabolism, attributing to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Practical applications: This research gives the public the guidance of the dietary intake of bioactive phospholipids from the perspective of nutrition and it supplies informational support for the development of functional foods containing DHA‐PL participating to the prevention of chronic metabolic diseases in humans. In another aspect, this research also provides an important direction for the development and utilization of marine aquatic raw materials since these materials are the best sources of n‐3 polyunsaturated fatty acid enriched‐phospholipids. Dietary egg yolk phospholipids, soybean phospholipids, and marine docosahexaenoic acid‐enriched phospholipids (DHA‐PL) could efficiently improve obesity‐related metabolic disorders in mice. Notably, DHA‐PL, rich in n‐3 PUFA, exhibited the best ameliorative effects, especially on the lipid metabolism, which could be attributed to the better inhibition of SREBP‐1c mediated lipogenesis and the elevation of hepatic lipolysis. Such findings would be useful in the development of functional foods containing DHA‐PL participating to prevent chronic metabolic disease in humans.

MyD88 Determines the Protective Effects of Fish Oil and Perilla Oil Against Metabolic Disorders and Inflammation in Adipose Tissue from Mice Fed a High-Fat Diet

Omega-3 Polyunsaturated Fatty Acids Antagonize Macrophage Inflammation Via Activation of Ampk/Sirt1 Pathway

Effects of Fish Oil, Lipid Mediators, Derived from Docosahexaenoic Acid, and Their Co-Treatment against Lipid Metabolism Dysfunction and Inflammation in HFD Mice and HepG2 Cells

Long-Term Dietary Epa or Dha Supplementation Do Not Ameliorate Obesity but Improve Glucose Homeostasis Via Gut-Adipose Axis in Already Obese Mice

Mussel Oil is Superior to Fish Oil in Preventing Atherosclerosis of ApoE−/− Mice

Comparative Study of DHA‐enriched Phospholipids and EPA‐enriched Phospholipids on Metabolic Disorders in Diet‐induced‐obese C57BL/6J Mice

Marine Algae Oils from Phaeodactylum Tricornutum and Laminaria Japonica Alleviate Obesity, Insulin Resistance, and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice

Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.

Oral Supplementation with Three Vegetable Oils Differing in Fatty Acid Composition Alleviates High-Fat Diet-Induced Obesity in Mice by Regulating Inflammation and Lipid Metabolism

Protective Role of N6/n3 PUFA Supplementation with Varying DHA/EPA Ratios Against Atherosclerosis in Mice

Mechanisms Mediating Tart Cherry and Fish Oil Metabolic Effects in Diet-Induced (C57BL/6J) and Genetically (TALYHO/Jng) Obese Mice

Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice

Dietary Supplementation with Fish Oil Alters the Expression Levels of Proteins Governing Mitochondrial Dynamics and Prevents High-Fat Diet-Induced Endothelial Dysfunction.

Fish Oil Alleviates Activation Of The Hypothalamic-Pituitary-Adrenal Axis Associated With Inhibition Of Tlr4 And Nod Signaling Pathways In Weaned Piglets After A Lipopolysaccharide Challenge

Fish Oil Ameliorates Trimethylamine N-Oxide-Exacerbated Glucose Intolerance in High-Fat Diet-Fed Mice

n-3 PUFA added to high-fat diets affect differently adiposity and inflammation when carried by phospholipids or triacylglycerols in mice

Endogenously Generated Omega‐3 Fatty Acids Attenuate Vascular Inflammation and Neointimal Hyperplasia by Interaction with Free Fatty Acid Receptor 4 in Mice

Perilla, sunflower, and tea seed oils as potential dietary supplements with anti-obesity effects by modulating the gut microbiota composition in mice fed a high-fat diet

ω3‐polyunsaturated fatty acids suppress lipoprotein‐associated phospholipase A2 expression in macrophages and animal models

Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats

Docosahexaenoic Acid‐enriched Phospholipids Exhibit Superior Effects on Obesity‐related Metabolic Disorders to Egg Yolk Phospholipids and Soybean Phospholipids in Mice